Revenues increased 7% yoy to $46.6 million Leniolisib launch on track for Q1 2023 following previously announced positive pivotal data Strong cash flow from operations supporting investments
Clover Provides Corporate Update and 2022 Priorities forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Soligenix Corporate Update Letter - Key Highlights and Upcoming Catalysts - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing.